Literature DB >> 12850379

Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors.

Chitra Sarkar1, Parthaprasad Chattopadhyay, Angela Mercy Ralte, Ashok K Mahapatra, Subrata Sinha.   

Abstract

We had previously reported that loss of heterozygosity (LOH) of the D17S379 locus on 17p13.3 was significantly more frequent in high-grade gliomas (anaplastic astrocytoma, AA; glioblastoma multiforme, GBM) than in those of a low-grade diffuse astrocytoma (DA); however, this was independent of alterations at the TP53 locus, We also showed that LOH of D17S379 was associated with positive staining for p53 protein on immunohistochemistry, but LOH of the TP53 gene had no such association. In this work we show that cell proliferation as determined by MIB-1 labeling index (LI) was significantly higher in tumors with LOH of D17S379 than those with no LOH (NLOH). In accord with our previous results, p53 protein immunopositivity was also associated with increased MIB-1 LI; however, we observed no such association of LI with TP53 LOH. The results further confirm that alteration of one or more putative tumor suppressor loci at 17p13.3 is associated with increased proliferation in astrocytic tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850379     DOI: 10.1016/s0165-4608(02)00937-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors.

Authors:  Tapasya Srivastava; Kunzang Chosdol; Parthaprasad Chattopadhayay; Chitra Sarkar; Ashok K Mahapatra; Subrata Sinha
Journal:  J Neurooncol       Date:  2006-10-04       Impact factor: 4.130

2.  P53 gene mutation and expression of MDM2, P53, P16 protein and their relationship in human glioma.

Authors:  Wen Cui; Renliang Wu; Huiling Cao; Jifa Gao; Xu Wang; Qiwei Ren
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  Apoptosis and proliferation: correlation with p53 in astrocytic tumours.

Authors:  Chitra Sarkar; Asis Kumar Karak; Neera Nath; Mehar Chand Sharma; Ashok Kumar Mahapatra; Parthoprasad Chattopadhyay; Subrata Sinha
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

4.  Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population.

Authors:  S Mitra; S Banerjee; C Misra; R K Singh; A Roy; A Sengupta; C K Panda; S Roychoudhury
Journal:  J Clin Pathol       Date:  2006-11-01       Impact factor: 3.411

5.  Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region.

Authors:  Carola Hedberg Oldfors; Diego Garcia Dios; Anna Linder; Kittichate Visuttijai; Emma Samuelson; Sandra Karlsson; Staffan Nilsson; Afrouz Behboudi
Journal:  BMC Genet       Date:  2015-07-14       Impact factor: 2.797

6.  Only missense mutations affecting the DNA binding domain of p53 influence outcomes in patients with breast carcinoma.

Authors:  Frédérique Végran; Magali Rebucci; Sandy Chevrier; Muriel Cadouot; Romain Boidot; Sarab Lizard-Nacol
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.